Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Department of Ultrasound, the Eastern Hospital of the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Ann Palliat Med. 2021 Mar;10(3):2577-2583. doi: 10.21037/apm-20-1381. Epub 2021 Feb 7.
To explore the prognostic role of ovarian endometriosis in symptomatic adenomyosis patients underwent uterine artery embolization (UAE).
This was a retrospective, single-center study. A total of 76 patients with adenomyosis who underwent UAE in The First Affiliated Hospital of Sun Yat-sen University between May 2009 and July 2016 were enrolled in this study. These patients were divided into two groups based on whether complicated with ovarian endometriosis. After UAE, the patients were followed up for 12 months. The improvements of dysmenorrhea and menorrhagia were evaluated according to the symptom relief criteria. The improvement rates in both groups were analyzed and compared.
Among the 76 patients with adenomyosis, 17 (22.3%) were diagnosed with OE and 59 (77.6%) were non-OE. In the OE group, all patients (17/17, 100%) had dysmenorrhea and 11 (11/17, 64.7%) had menorrhagia. In non-OE group, 57 patients (57/59, 96.6%) had dysmenorrhea and 50 (50/59, 84.7%) had menorrhagia. The improvement rates of dysmenorrhea in the two groups were 47.1% (OE group) and 86.0% (non-OE group), respectively (P<0.05). The improvement rates of menorrhagia in the two groups were 63.6% (OE group) and 84.0% (non-OE group), respectively (P=0.263).
Patients without OE showed a lower incidence of dysmenorrhea and may have an advantage in the improvement of dysmenorrhea compared with those with OE when they underwent UAE. However, no significant difference was observed in the improvement of menorrhagia.
探讨卵巢子宫内膜异位症（ovarian endometriosis，OE）在接受子宫动脉栓塞术（uterine artery embolization，UAE）的有症状腺肌病患者中的预后作用。
这是一项回顾性、单中心研究。共纳入 2009 年 5 月至 2016 年 7 月在中山大学附属第一医院接受 UAE 的 76 例腺肌病患者，根据是否合并 OE 将这些患者分为两组。UAE 后对患者进行 12 个月的随访，根据症状缓解标准评估痛经和月经过多的改善情况，分析比较两组的改善率。
76 例腺肌病患者中，17 例（22.3%）诊断为 OE，59 例（77.6%）为非 OE。在 OE 组中，所有患者（17/17，100%）均有痛经，11 例（11/17，64.7%）有月经过多；在非 OE 组中，57 例（57/59，96.6%）有痛经，50 例（50/59，84.7%）有月经过多。两组痛经改善率分别为 47.1%（OE 组）和 86.0%（非 OE 组）（P<0.05）；两组月经过多的改善率分别为 63.6%（OE 组）和 84.0%（非 OE 组）（P=0.263）。
无 OE 的患者痛经发生率较低，与合并 OE 的患者相比，在接受 UAE 时痛经改善可能更具优势；但在月经过多的改善方面，两组间无显著差异。
